Mounjaro was expected to surge in price. Picture: Getty By Jacob Paul The pharmaceutical giant behind the ‘King Kong’ of weight loss jabs has offered a discounted deal to UK suppliers to soften the blow of expected price hikes. Listen to this article Loading audio... Eli Lilly, the US manufacturer of Mounjaro, appeared to U-turn on an expected price rise of up to 170 per cent next week. The firm will reportedly sell the highest dose to suppliers for £247.50, down from an anticipated £330. However, this still marks a mark-up on the current typical cost of £122. Pharmacies and other private weight-loss services will apply their own mark-up on the weight loss jab – which is used by around 750,000 Brits. "Pricing is a matter for the manufacturers and pharmacies will do all they can to support patients when prices change," Olivier Picard, Chair of the National Pharmacy Association said. He added: "This rebate will mitigate some of the impact of the increase in Mounjaro prices faced by pharmacies but patients should still anticipate seeing a rise in prices from 1st September. Read more: US drug giant to temporarily halt UK Mounjaro orders Read more: Lib Dems call for watchdog investigation after Mounjaro sales suspended in the UK Pre-filled injection pens of 2.5mg, 5mg and 7.5mg doses of Mounjaro, the tirzepatide weight loss medication manufactured by US manufacturer Eli Lilly. Picture: Alamy

Source: LBC